KemPharm, Inc. (KMPH) Social Stream



KemPharm, Inc. (KMPH): $6.44

0.27 (+4.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KMPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 455

in industry

Kempharm Inc (KMPH) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Kempharm Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 2 $28 $10 $19 $6.7 183.58%

The Trend in the Analyst Price Target


KMPH's average price target has moved down $0 over the prior 69 days.

Over the past 35 weeks, KMPH's average upside potential has been 92.52%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-04 2 28 10 19 9.59 98.12%
2021-11-12 2 28 10 19 9.12 108.33%
2021-03-11 1 28 24 26 9.98 160.52%
2021-06-05 2 28 10 19 11.32 67.84%
2021-06-08 2 28 10 19 12.21 55.61%

KMPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


Over the past 21 months, KMPH's average broker recommendation rating worsened by 1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • KMPH has a higher number of analysts covering the stock than 5.29% of Pharmaceutical Products stocks.
  • Kempharm Inc's variance in analysts' estimates is lower than 8.38% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of Healthcare stocks, Kempharm Inc's average analyst price target is higher than 31.67% of them.
  • In terms of how Kempharm Inc fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 67.68% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Kempharm Inc are KMDA, KALV, and KALA.

What is the outlook for KMPH? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.4128 seconds.